Compare BMRA & GIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRA | GIXI |
|---|---|---|
| Founded | 1971 | 1978 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 9.7M |
| IPO Year | 1995 | N/A |
| Metric | BMRA | GIXI |
|---|---|---|
| Price | $1.68 | $4.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.3K | ★ 1.4M |
| Earning Date | 10-15-2026 | 11-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,453,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.45 | $3.56 |
| 52 Week High | $3.09 | $8.34 |
| Indicator | BMRA | GIXI |
|---|---|---|
| Relative Strength Index (RSI) | 32.36 | 44.03 |
| Support Level | $1.50 | $3.79 |
| Resistance Level | $1.71 | $8.34 |
| Average True Range (ATR) | 0.10 | 0.74 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 14.81 | 12.58 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
Gix Internet Ltd provides infrastructure for managing and authorizing autonomous systems, including autonomous mobile robots (AMRs), automated guided vehicles (AGVs), humanoid robots, robotaxis, shuttles, drones, and human workforces. The company's platform provides: mission generation and orchestration across mixed-fleet environments; real-time authorization and policy-gate enforcement for regulatory compliance; and cryptographically signed records of authorized actions for regulatory compliance.